Existing investor Agilent helped the biomedical analysis technology developer close a series C round that pushed its overall funding past $110m.

Mobilion Systems, a US-based biomedical equipment spinout of Pacific Northwest National Laboratory (PNNL), completed a $60m series C round yesterday featuring diagnostics services provider Agilent Technologies.

Investment firm D1 Capital Partners led the round, which also attracted IP Group, aMoon, Hostplus and Cultivation Capital.

Founded in 2015, Mobilion develops analytical instruments to separate, identify and analyse proteins and examine molecules. The technology can be used for early disease detection and to develop treatments that target the root causes of health…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Email LinkedIn